(Q38457525)

3 September 2017

title

The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users (English)

1 reference

Ildefonso Hernández-Aguado

3 September 2017

Blanca Lumbreras

2

0 references

Santiago Pérez-Hoyos

object named as

Santiago Pérez-Hoyos

series ordinal

4

0 references

object named as

Ildefonso Hernández-Aguado

series ordinal

5

0 references

Inmaculada Ferreros

series ordinal

1

object named as

Inmaculada Ferreros

1 reference

3 September 2017

Isabel Hurtado

3

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

3 September 2017

1 reference

3 September 2017

volume

103

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

651-659

1 reference

Mortality risk among new onset injection drug users

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

The quantification of mortality resulting from the regular use of illicit opiates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Impact of HIV infection on mortality in a cohort of injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Self-reported antiretroviral therapy in injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

AIDS-free time and survival of an injecting drug users HIV seroconvertors cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Determinants of HIV-1 infection in intravenous drug users in Valencia, Spain, 1987-1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Sharing of injection equipment among 3755 intravenous drug users in Valencia, Spain, 1987-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Tutorial in biostatistics: competing risks and multi-state models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

HIV and hepatitis C coinfection within the CAESAR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Multiple codification of the causes of death: from dying "of" to dying "from"

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02135.X

10.1111/J.1360-0443.2008.02135.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference